PL Lodz Watala C: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{MiPNetLab | {{MiPNetLab | ||
| | |institution=Department of Haemostasis and Haemostatic Disorders | ||
Β | |||
Department of Haemostasis and Haemostatic Disorders | |||
Medical University of Lodz | Medical University of Lodz | ||
Β | |address=113 Zeromskiego Street | ||
113 Zeromskiego Street | |area code=90-549 | ||
Β | |||
90-549 | |||
|city=Lodz | |city=Lodz | ||
|country=Poland | |country=Poland | ||
|weblink=[http://www.flawopiryna.pl/ flawopiryna] | |weblink=[http://www.flawopiryna.pl/ flawopiryna] | ||
| | |Contact=Watala C | ||
|MiPNetLab=Labieniec-Watala M, Dudzinska D, Novak J, Siewiera K | |||
|Status=O2k 2010- | |||
|info=[[Bioblast 2012]], [[IOC61]], [http://www.oroboros.at/?IOC55-56 IOC55-56] | |info=[[Bioblast 2012]], [[IOC61]], [http://www.oroboros.at/?IOC55-56 IOC55-56] | ||
}} | }} |
Revision as of 15:44, 8 March 2013
Areas of interest
- Mitochondrial respiratory capacity under normal and pathophysiological conditions (diabetes mellitus, atherothrombosis, brain-blood barrier disruption, cancerogenesis)
- Pharmacological modulation of mitochondrial function by selected pharmaceuticals of anti-diabetic activity
- Targeting of biochemical and molecular burden of diabetes
Gentle Science
- Link to Gentle Science.